Valencia Nutrition Limited (BOM:542910)
India · Delayed Price · Currency is INR 64.94
0.00 (0.00%)
At close: Oct 5, 2026
Valencia Nutrition Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 78.78 | 84.71 | 13.35 | 14.61 | - |
Other Revenue | 8.16 | 0.3 | - | - | - |
| 86.94 | 85.01 | 13.35 | 14.61 | - | |
Revenue Growth | 2.27% | 536.58% | -8.57% | 52.97% | - |
Cost of Revenue | 31.12 | 44.84 | 17.78 | 15.38 | 0.22 |
Gross Profit | 55.82 | 40.17 | -4.43 | -0.77 | -0.22 |
Selling, General & Admin | 25.08 | 12.8 | 5.88 | 3.9 | 2 |
Other Operating Expenses | 12.33 | 17.74 | 2.71 | 7.22 | 3.42 |
Operating Expenses | 43.79 | 32.66 | 9.11 | 11.86 | 6.17 |
Operating Income | 12.03 | 7.51 | -13.54 | -12.63 | -6.39 |
Interest Expense | -1.34 | -1.25 | -0.01 | - | -0.07 |
Interest & Investment Income | 0.24 | 5.44 | 0.01 | - | - |
Other Non Operating Income (Expenses) | -0 | -0.24 | -0.3 | - | - |
EBT Excluding Unusual Items | 10.93 | 11.46 | -13.85 | -12.63 | -6.46 |
Gain (Loss) on Sale of Investments | - | -0.72 | - | - | - |
Other Unusual Items | - | - | - | - | -0.16 |
Pretax Income | 10.93 | 10.74 | -13.85 | -12.63 | -6.62 |
Net Income | 10.93 | 10.74 | -13.85 | -12.63 | -6.62 |
Net Income to Common | 10.93 | 10.74 | -13.85 | -12.63 | -6.62 |
Net Income Growth | 1.73% | - | - | - | - |
Shares Outstanding (Basic) | 18 | 17 | 6 | 6 | 6 |
Shares Outstanding (Diluted) | 21 | 17 | 6 | 6 | 6 |
Shares Change | 23.75% | 204.02% | - | - | - |
EPS (Basic) | 0.60 | 0.63 | -2.48 | -2.26 | -1.18 |
EPS (Diluted) | 0.52 | 0.63 | -2.48 | -2.26 | -1.18 |
EPS Growth | -17.79% | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -264.22 | -196.65 | -29.81 | -15.53 | -13.49 |
Free Cash Flow Per Share | -12.57 | -11.58 | -5.34 | -2.78 | -2.42 |
Gross Margin | 64.20% | 47.26% | -33.17% | -5.28% | - |
Operating Margin | 13.84% | 8.84% | -101.42% | -86.46% | - |
Profit Margin | 12.57% | 12.63% | -103.69% | -86.46% | - |
Free Cash Flow Margin | -303.90% | -231.33% | -223.22% | -106.31% | - |
EBITDA | 18.42 | 9.64 | -13.02 | -11.89 | -5.63 |
EBITDA Margin | 21.18% | 11.33% | -97.50% | -81.42% | - |
D&A For EBITDA | 6.39 | 2.12 | 0.52 | 0.74 | 0.76 |
EBIT | 12.03 | 7.51 | -13.54 | -12.63 | -6.39 |
EBIT Margin | 13.84% | 8.84% | -101.42% | -86.46% | - |
Revenue as Reported | 95.78 | 91.2 | 16.48 | 14.61 | 0 |
Advertising Expenses | 0.25 | - | - | - | - |